Assessment of human antihuman antibodies to eculizumab after long-term treatment in patients with paroxysmal nocturnal hemoglobinuria

被引：14
|
作者：
Hillmen, Peter [1 ]
Muus, Petra [2 ]
Szer, Jeffrey [3 ,4 ]
Hill, Anita [5 ]
Hoechsmann, Britta [6 ,7 ]
Kulasekararaj, Austin
Risitano, Antonio M. [8 ,9 ]
Van Den Neste, Eric [10 ]
Liljeholm, Maria [11 ]
Ebrahim, Kurt S. [12 ]
Bedrosian, Camille L. [13 ]
Gao, Xiang [13 ]
Ames, Donna [13 ]
Socie, Gerard [14 ]
机构：
[1] St James Univ Hosp, Sect Expt Haematol, Level 6,Wellcome Trust Brenner Bldg,Beckett St, Leeds LS9 7TF, W Yorkshire, England
[2] Radboud Univ Nijmegen, Med Ctr, Dept Hematol, NL-6525 ED Nijmegen, Netherlands
[3] Royal Melbourne Hosp, Dept Clin Haematol, Melbourne, Vic, Australia
[4] Royal Melbourne Hosp, BMT Serv, Melbourne, Vic, Australia
[5] Leeds Teaching Hosp, St James Inst Oncol, Dept Haematol, Leeds, W Yorkshire, England
[6] Univ Ulm, Inst Clin Transfus Med & Immunogenet Ulm, Inst Transfus Med, German Red Cross Blood Transfus Serv Baden Wurtte, D-89069 Ulm, Germany
[7] Univ Hosp Ulm, Ulm, Germany
[8] Kings Coll Hosp London, London, England
[9] Univ Naples Federico II, Dipartimento Med Clin & Chirurg, Naples, Italy
[10] Clin Univ UCL St Luc, Dept Hematol, Brussels, Belgium
[11] Univ Umea Hosp, Dept Hematol, S-90185 Umea, Sweden
[12] New England Canc Specialists, Scarborough, ME USA
[13] Alex Pharmaceut Inc, Cheshire, CT USA
[14] Hosp St Louis, AP HP Hematol, Paris, France
来源：
AMERICAN JOURNAL OF HEMATOLOGY | 2016年 / 91卷 / 03期
关键词：
COMPLEMENT INHIBITOR ECULIZUMAB; IMMUNOGENICITY;
D O I：
10.1002/ajh.24280
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E16 / E17
页数：2
相关论文
共 50 条
  • [31] Long-Term Safety and Efficacy of Pegcetacoplan Treatment in Adults with Paroxysmal Nocturnal Hemoglobinuria
    Patriquin, Christopher J.
    Bogdanovic, Andrija
    Griffin, Morag
    Kelly, Richard
    Maciejewski, Jaroslaw P.
    Mulherin, Brian
    de Latour, Regis Peffault
    Roeth, Alexander
    Selvaratnam, Veena
    Szer, Jeffrey
    Savage, Jessica
    Horneff, Regina
    Tan, Lisa
    Yeh, Michael
    Panse, Jens
    BLOOD, 2022, 140 : 2921 - 2923
  • [32] Effects of eculizumab treatment on quality of life in patients with paroxysmal nocturnal hemoglobinuria in Japan
    Yasutaka Ueda
    Naoshi Obara
    Yuji Yonemura
    Hideyoshi Noji
    Masayoshi Masuko
    Yoshinobu Seki
    Katsuya Wada
    Takahisa Matsuda
    Hirozumi Akiyama
    Takayuki Ikezoe
    Shigeru Chiba
    Yoshinobu Kanda
    Tatsuya Kawaguchi
    Tsutomu Shichishima
    Hideki Nakakuma
    Shinichiro Okamoto
    Jun-ichi Nishimura
    Yuzuru Kanakura
    Haruhiko Ninomiya
    International Journal of Hematology, 2018, 107 : 656 - 665
  • [33] Eculizumab opens a new era of treatment for paroxysmal nocturnal hemoglobinuria
    Schrezenmeier, Hubert
    Hoechsmann, Britta
    EXPERT REVIEW OF HEMATOLOGY, 2009, 2 (01) : 7 - 16
  • [34] Treatment of paroxysmal nocturnal hemoglobinuria in pregnancy with eculizumab: A case report
    Fassett, Michael J.
    Lopez, Adrian L. Hernandez
    CASE REPORTS IN WOMENS HEALTH, 2021, 30
  • [35] Effects of eculizumab treatment on quality of life in patients with paroxysmal nocturnal hemoglobinuria in Japan
    Ueda, Yasutaka
    Obara, Naoshi
    Yonemura, Yuji
    Noji, Hideyoshi
    Masuko, Masayoshi
    Seki, Yoshinobu
    Wada, Katsuya
    Matsuda, Takahisa
    Akiyama, Hirozumi
    Ikezoe, Takayuki
    Chiba, Shigeru
    Kanda, Yoshinobu
    Kawaguchi, Tatsuya
    Shichishima, Tsutomu
    Nakakuma, Hideki
    Okamoto, Shinichiro
    Nishimura, Jun-ichi
    Kanakura, Yuzuru
    Ninomiya, Haruhiko
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2018, 107 (06) : 656 - 665
  • [36] Paroxysmal nocturnal hemoglobinuria: Test to monitor the action of eculizumab treatment
    Arcavi, Miriam
    Ceballo, Fernanda
    Caracciolo, Maria Beatriz
    Lazarowski, Alberto
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2020, 42 (03) : 335 - 340
  • [37] EXTRAVASCULAR HEMOLYSIS DURING TREATMENT WITH ECULIZUMAB FOR PAROXYSMAL NOCTURNAL HEMOGLOBINURIA
    Graciaa, Sara
    Chonat, Satheesh
    PEDIATRIC BLOOD & CANCER, 2019, 66
  • [38] Paroxysmal Nocturnal Hemoglobinuria -- Hemolysis before and after Eculizumab.
    Risitano, Antonio M.
    Notaro, Rosario
    Luzzatto, Lucio
    Hill, Anita
    Kelly, Richard
    Hillmen, Peter
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (23): : 2270 - 2273
  • [39] Eculizumab Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH). the Argentinian Experience
    Brodsky, Andres L.
    Touliet, Valeria Soledad
    Rocaspana, Adriana
    Aldunate, Ximena
    Alzueta, Abel Esteban
    Barraza, Teresa
    Beguelin, Raul
    Carnpregher, Gabriel
    Beatriz Colin, Laura
    Dinardo, Pablo
    Gotta, Daniel
    Oliveira, Natalia
    Parodi, Claudia
    Perinotto, Gabriela
    Ramirez, Mario
    Rigada, Guillermina
    Ronzzetti, Rosanna
    Esther, Rosenfeld
    Blanca, Rossi
    Stivel, Miriam
    Zirone, Sandra
    BLOOD, 2015, 126 (23)
  • [40] Long-term follow-up of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab: post-marketing surveillance in Japan
    Ikezoe, Takayuki
    Noji, Hideyoshi
    Ueda, Yasutaka
    Kanda, Yoshinobu
    Okamoto, Shinichiro
    Usuki, Kensuke
    Matsuda, Takahisa
    Akiyama, Hirozumi
    Shimono, Akihiko
    Yonemura, Yuji
    Kawaguchi, Tatsuya
    Chiba, Shigeru
    Kanakura, Yuzuru
    Nishimura, Jun-Ichi
    Ninomiya, Haruhiko
    Obara, Naoshi
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2022, 115 (04) : 470 - 480
12345